Current Medical and Surgical Stroke Prevention Therapies for Patients with Carotid Artery Stenosis
- 13 May 2019
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Neurovascular Research
- Vol. 16 (1), 96-103
- https://doi.org/10.2174/1567202616666190131162811
Abstract
Carotid artery stenosis (CAS) is a marker of systemic atherosclerosis and patients with CAS are at high risk of vascular events in multiple vascular locations, including ipsilateral ischemic stroke. Both medical and surgical therapies have been demonstrated effective in reducing this risk. The optimal management for patients with asymptomatic carotid artery stenosis remains controversial. In patients with symptomatic CAS ≥70%, CEA has been demonstrated to reduce the risk of stroke. With risk of recurrent stroke being particularly high in the first 2 weeks after first event, CEA or carotid angioplasty with stenting provides maximal benefits to patients with symptomatic CAS ≥70% if performed within this «2-week» target. Several large ongoing trials are currently comparing the risks and benefits of carotid revascularization versus medical therapy alone.Keywords
This publication has 78 references indexed in Scilit:
- Combined Effects of Child and Adult Elevated Blood Pressure on Subclinical AtherosclerosisJournal of the American College of Cardiology, 2013
- Antithrombotic Therapy in Peripheral Artery Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Age and Outcomes After Carotid Stenting and EndarterectomyStroke, 2011
- Stenting versus Endarterectomy for Treatment of Carotid-Artery StenosisThe New England Journal of Medicine, 2010
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent StrokeThe New England Journal of Medicine, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991